The guidance, if finalized, would be the first to cover AI devices from design and development to post-market monitoring and risk management, according to a Jan. 6 news release from the agency.
The guidance highlights key areas, including strategies to address transparency, bias and performance monitoring.
The FDA has authorized more than 1,000 AI-enabled medical devices and the new guidance builds on previous efforts.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
